Equities

Sinovac Biotech Ltd

Sinovac Biotech Ltd

Actions
  • Price (EUR)5.50
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Feb 22 2019.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
OPERATIONS
Net income(258)8814,459
Depreciation/depletion14015484
Non-Cash items(137)14981
Cash taxes paid, supplemental(56)1,3221,488
Cash interest paid, supplemental5.351.112.80
Changes in working capital278(1081)461
Total cash from operations104(771)15,353
INVESTING
Capital expenditures(146)(403)(720)
Other investing and cash flow items, total(2778)(5357)(2304)
Total cash from investing(2924)(5760)(3024)
FINANCING
Financing cash flow items(316)264.32
Total cash dividends paid--(263)(1876)
Issuance (retirement) of stock, net0.6801.03
Issuance (retirement) of debt, net239(4.32)(26)
Total cash from financing(76)(241)(1897)
NET CHANGE IN CASH
Foreign exchange effects(115)(561)137
Net change in cash(3011)(7333)10,570
Net cash-begin balance/reserved for future use4,28611,6201,050
Net cash-end balance/reserved for future use1,2754,28611,620
SUPPLEMENTAL INCOME
Depreciation, supplemental14015484
Cash interest paid, supplemental5.351.112.80
Cash taxes paid, supplemental(56)1,3221,488
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.